Matrix metalloproteinase-9 (MMP9), Matrix metalloproteinase-2 (MMP2), and Urokinase-type plasminogen activator (uPA) (MMP9/MMP2/uPA)

The MMP9/MMP2 and uPA system is a coordinated group of extracellular proteases that play a fundamental role in the degradation of the extracellular matrix (ECM) and the basement membrane (PubMed, PMC). Matrix metalloproteinase-9 (MMP9) and Matrix metalloproteinase-2 (MMP2) are gelatinases that cleave type IV collagen, while the urokinase-type plasminogen activator (uPA) is a serine protease that initiates a proteolytic cascade by converting plasminogen into plasmin, which in turn activates various MMPs (MDPI, PMC). This system is essential for physiological processes such as tissue remodeling, wound healing, and trophoblast invasion during pregnancy, but its dysregulation is a hallmark of cancer progression (NIH, PMC). In malignant environments, the overactivation of these enzymes facilitates tumor cell extravasation, migration, and the release of pro-angiogenic factors, leading to metastasis and increased tumor vascularization (PubMed, ResearchGate). Clinically, elevated levels of MMP9, MMP2, and uPA are utilized as prognostic biomarkers for aggressive disease and poor patient outcomes in cancers such as breast, prostate, and colorectal carcinoma (MDPI, ResearchGate). Although early broad-spectrum MMP inhibitors like marimastat and batimastat showed promise in preclinical models, they largely failed in clinical trials due to significant toxicity, most notably musculoskeletal syndrome, and a lack of specificity (PubMed, MDPI). Modern therapeutic approaches are shifting toward the development of highly selective inhibitors, antibody-based therapies, and the use of natural compounds like plumbagin and daurinol that can simultaneously downregulate the expression of multiple components within this proteolytic network (PubMed, Oncotarget).

Other names

Gelatinase BGelatinase AUrokinasePlasminogen activator, urinary-typePLAU92 kDa type IV collagenase72 kDa type IV collagenaseuPA/uPAR systemGelatinase system

Inhibition of proteolytic activity to prevent the degradation of the extracellular matrix and basement membrane, thereby blocking tumor cell invasion, migration, and angiogenesis.